AJOONI — Ajooni Biotech Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹649.36m
- IN₹815.80m
- IN₹1.82bn
Annual cashflow statement for Ajooni Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 14.6 | 15.8 | 30 | 43.3 | 57.4 |
| Depreciation | |||||
| Non-Cash Items | 5.51 | 3.8 | -21.2 | -5.55 | -6.24 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 5.61 | -85.4 | -57 | -226 | -131 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 36.8 | -55.8 | -39.5 | -177 | -57.3 |
| Capital Expenditures | -21.2 | -28.6 | -56 | -20.3 | -180 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 2.27 | -130 | 132 | -151 | 22.6 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -19 | -158 | 76.4 | -171 | -158 |
| Financing Cash Flow Items | -5.4 | -4.78 | -5.57 | -3.34 | -7.29 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -19.7 | 217 | -35.7 | 248 | 151 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.87 | 2.52 | 1.19 | -100 | -64.1 |